Epidemiology and Pathogenesis of Ulcerative Colitis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Abraham, 2012, Fecal markers: calprotectin and lactoferrin, Gastroenterol Clin North Am, 41, 483, 10.1016/j.gtc.2012.01.007
Ng, 2013, Geographical variability and environmental risk factors in inflammatory bowel disease, Gut, 62, 630, 10.1136/gutjnl-2012-303661
Cohen, 2010, Systematic review: the costs of ulcerative colitis in Western countries, Aliment Pharmacol Ther, 31, 693, 10.1111/j.1365-2036.2010.04234.x
Kirsner, 1979, The local and systemic complications of inflammatory bowel disease, JAMA, 242, 1177, 10.1001/jama.1979.03300110049028
Cosnes, 2011, Epidemiology and natural history of inflammatory bowel diseases, Gastroenterology, 140, 1785, 10.1053/j.gastro.2011.01.055
Ng, 2018, Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies, Lancet, 390, 2769, 10.1016/S0140-6736(17)32448-0
Molodecky, 2012, Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review, Gastroenterology, 142, 46, 10.1053/j.gastro.2011.10.001
Loftus, 2004, Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences, Gastroenterology, 126, 1504, 10.1053/j.gastro.2004.01.063
Charpentier, 2014, Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study, Gut, 63, 423, 10.1136/gutjnl-2012-303864
Nguyen, 2019, The impact of inflammatory bowel disease in Canada 2018: IBD in seniors, J Can Assoc Gastroenterol, 2, S68
Stepaniuk, 2015, Characterization of inflammatory bowel disease in elderly patients: a review of epidemiology, current practices and outcomes of current management strategies, Can J Gastroenterol Hepatol, 29, 327, 10.1155/2015/136960
Benchimol, 2019, The impact of inflammatory bowel disease in canada 2018: a scientific report from the Canadian Gastro-intestinal Epidemiology Consortium to Crohn's and Colitis Canada, J Can Assoc Gastroenterol, 2, S1
Ha, 2014, Clinical implications of ageing for the management of IBD, Nat Rev Gastroenterol Hepatol, 11, 128, 10.1038/nrgastro.2013.241
Kaplan, 2015, The global burden of IBD: from 2015 to 2025, Nat Rev Gastroenterol Hepatol, 12, 720, 10.1038/nrgastro.2015.150
Kaplan, 2017, Understanding and preventing the global increase of inflammatory bowel disease, Gastroenterology, 152, 313, 10.1053/j.gastro.2016.10.020
Bernstein, 2008, Assessing environmental risk factors affecting the inflammatory bowel diseases: a joint workshop of the Crohn's & Colitis Foundations of Canada and the USA, Inflamm Bowel Dis, 14, 1139, 10.1002/ibd.20494
Ekbom, 1990, Perinatal risk factors for inflammatory bowel disease: a case-control study, Am J Epidemiol, 132, 1111, 10.1093/oxfordjournals.aje.a115754
Klement, 2008, Childhood hygiene is associated with the risk for inflammatory bowel disease: a population-based study, Am J Gastroenterol, 103, 1775, 10.1111/j.1572-0241.2008.01905.x
Kaplan, 2016, Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China, Lancet Gastroenterol Hepatol, 1, 307, 10.1016/S2468-1253(16)30077-2
Sands, 2007, The role of TNFalpha in ulcerative colitis, J Clin Pharmacol, 47, 930, 10.1177/0091270007301623
Van Klinken, 1999, Sulphation and secretion of the predominant secretory human colonic mucin MUC2 in ulcerative colitis, Gut, 44, 387, 10.1136/gut.44.3.387
Heller, 2005, Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution, Gastroenterology, 129, 550, 10.1016/j.gastro.2005.05.002
Dubuquoy, 2003, Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis, Gastroenterology, 124, 1265, 10.1016/S0016-5085(03)00271-3
Jiang, 1998, PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines, Nature, 391, 82, 10.1038/34184
Hart, 2005, Characteristics of intestinal dendritic cells in inflammatory bowel diseases, Gastroenterology, 129, 50, 10.1053/j.gastro.2005.05.013
Zhang, 1999, Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes, J Biol Chem, 274, 7611, 10.1074/jbc.274.12.7611
Danese, 2018, Positioning tofacitinib in the treatment algorithm of moderate to severe ulcerative colitis, Inflamm Bowel Dis, 24, 2106
Danese, 2016, JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines, Am J Physiol Gastrointest Liver Physiol, 310, G155, 10.1152/ajpgi.00311.2015
Heller, 2008, Epithelial apoptosis is a prominent feature of the epithelial barrier disturbance in intestinal inflammation: effect of pro-inflammatory interleukin-13 on epithelial cell function, Mucosal Immunol, 1, S58, 10.1038/mi.2008.46
Briskin, 1997, Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue, Am J Pathol, 151, 97
Rosario, 2017, A Review of the clinical pharmacokinetics, pharmacodynamics, and immunogenicity of vedolizumab, Clin Pharmacokinet, 56, 1287, 10.1007/s40262-017-0546-0
Orholm, 2000, Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study, Scand J Gastroenterol, 35, 1075, 10.1080/003655200451207
Tysk, 1988, Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking, Gut, 29, 990, 10.1136/gut.29.7.990
Ananthakrishnan, 2015, Epidemiology and risk factors for IBD, Nat Rev Gastroenterol Hepatol, 12, 205, 10.1038/nrgastro.2015.34
Jostins, 2012, Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease, Nature, 491, 119, 10.1038/nature11582
Liu, 2015, Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations, Nat Genet, 47, 979, 10.1038/ng.3359
McGovern, 2015, Genetics of inflammatory bowel diseases, Gastroenterology, 149, 1163, 10.1053/j.gastro.2015.08.001
Hindorff, 2009, Potential etiologic and functional implications of genome-wide association loci for human diseases and traits, Proc Natl Acad Sci U S A, 106, 9362, 10.1073/pnas.0903103106
Bouma, 2003, The immunological and genetic basis of inflammatory bowel disease, Nat Rev Immunol, 3, 521, 10.1038/nri1132
Khor, 2011, Genetics and pathogenesis of inflammatory bowel disease, Nature, 474, 307, 10.1038/nature10209
Chapman-Kiddell, 2010, Role of diet in the development of inflammatory bowel disease, Inflamm Bowel Dis, 16, 137, 10.1002/ibd.20968
Persson, 1992, Diet and inflammatory bowel disease: a case-control study, Epidemiology, 3, 47, 10.1097/00001648-199201000-00009
Tragnone, 1995, Dietary habits as risk factors for inflammatory bowel disease, Eur J Gastroenterol Hepatol, 7, 47
Desai, 2016, A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility, Cell, 167, 1339, 10.1016/j.cell.2016.10.043
Gill, 2018, Review article: short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders, Aliment Pharmacol Ther, 48, 15, 10.1111/apt.14689
Roberts, 2010, Translocation of Crohn's disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers, Gut, 59, 1331, 10.1136/gut.2009.195370
Ananthakrishnan, 2013, A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis, Gastroenterology, 145, 970, 10.1053/j.gastro.2013.07.050
Andersen, 2018, Fibre intake and the development of inflammatory bowel disease: A European prospective multi-centre cohort study (EPIC-IBD), J Crohns Colitis, 12, 129, 10.1093/ecco-jcc/jjx136
Brotherton, 2016, Avoidance of fiber is associated with greater risk of Crohn's disease flare in a 6-month period, Clin Gastroenterol Hepatol, 14, 1130, 10.1016/j.cgh.2015.12.029
D'Souza, 2008, Dietary patterns and risk for Crohn's disease in children, Inflamm Bowel Dis, 14, 367, 10.1002/ibd.20333
Thornton, 1979, Diet and Crohn's disease: characteristics of the pre-illness diet, Br Med J, 2, 762, 10.1136/bmj.2.6193.762
Le Leu, 2013, Dietary red meat aggravates dextran sulfate sodium-induced colitis in mice whereas resistant starch attenuates inflammation, Dig Dis Sci, 58, 3475, 10.1007/s10620-013-2844-1
Hou, 2011, Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature, Am J Gastroenterol, 106, 563, 10.1038/ajg.2011.44
Ananthakrishnan, 2014, Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease, Gut, 63, 776, 10.1136/gutjnl-2013-305304
Hart, 2008, Diet in the aetiology of ulcerative colitis: a European prospective cohort study, Digestion, 77, 57, 10.1159/000121412
Tjonneland, 2009, Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case-control study within a European prospective cohort study, Gut, 58, 1606, 10.1136/gut.2008.169078
Qin, 2012, Etiology of inflammatory bowel disease: a unified hypothesis, World J Gastroenterol, 18, 1708, 10.3748/wjg.v18.i15.1708
Hansen, 2011, Environmental factors in inflammatory bowel disease: a case-control study based on a Danish inception cohort, J Crohns Colitis, 5, 577, 10.1016/j.crohns.2011.05.010
Racine, 2016, Dietary patterns and risk of inflammatory bowel disease in Europe: results from the EPIC Study, Inflamm Bowel Dis, 22, 345, 10.1097/MIB.0000000000000638
Parigi, 2015, Breast milk and solid food shaping intestinal immunity, Front Immunol, 6, 415, 10.3389/fimmu.2015.00415
Renz, 2011, The impact of perinatal immune development on mucosal homeostasis and chronic inflammation, Nat Rev Immunol, 12, 9, 10.1038/nri3112
Rogier, 2014, Lessons from mother: long-term impact of antibodies in breast milk on the gut microbiota and intestinal immune system of breastfed offspring, Gut Microbes, 5, 663, 10.4161/19490976.2014.969984
Xu, 2017, Systematic review with meta-analysis: breastfeeding and the risk of Crohn's disease and ulcerative colitis, Aliment Pharmacol Ther, 46, 780, 10.1111/apt.14291
Dave, 2012, The human gut microbiome: current knowledge, challenges, and future directions, Transl Res, 160, 246, 10.1016/j.trsl.2012.05.003
Jandhyala, 2015, Role of the normal gut microbiota, World J Gastroenterol, 21, 8787, 10.3748/wjg.v21.i29.8787
Frank, 2007, Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases, Proc Natl Acad Sci U S A, 104, 13780, 10.1073/pnas.0706625104
Lathrop, 2011, Peripheral education of the immune system by colonic commensal microbiota, Nature, 478, 250, 10.1038/nature10434
Brown, 2012, Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease, Nutrients, 4, 1095, 10.3390/nu4081095
Morgan, 2012, Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment, Genome Biol, 13, R79, 10.1186/gb-2012-13-9-r79
Nagalingam, 2012, Role of the microbiota in inflammatory bowel diseases, Inflamm Bowel Dis, 18, 968, 10.1002/ibd.21866
Spor, 2011, Unravelling the effects of the environment and host genotype on the gut microbiome, Nat Rev Microbiol, 9, 279, 10.1038/nrmicro2540
Derikx, 2016, Probiotics and prebiotics in ulcerative colitis, Best Pract Res Clin Gastroenterol, 30, 55, 10.1016/j.bpg.2016.02.005
Prantera, 2008, What role do antibiotics have in the treatment of IBD?, Nat Clin Pract Gastroenterol Hepatol, 5, 670, 10.1038/ncpgasthep1273
Seibold, 1998, pANCA represents a cross-reactivity to enteric bacterial antigens, J Clin Immunol, 18, 153, 10.1023/A:1023203118100
Bernstein, 2008, Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases, Gut, 57, 1185, 10.1136/gut.2007.122143
Rausch, 2011, Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype, Proc Natl Acad Sci U S A, 108, 19030, 10.1073/pnas.1106408108
Harries, 1982, Non-smoking: a feature of ulcerative colitis, Br Med J, 284, 706, 10.1136/bmj.284.6317.706
Mahid, 2006, Smoking and inflammatory bowel disease: a meta-analysis, Mayo Clin Proc, 81, 1462, 10.4065/81.11.1462
Beaugerie, 2001, Impact of cessation of smoking on the course of ulcerative colitis, Am J Gastroenterol, 96, 2113, 10.1111/j.1572-0241.2001.03944.x
Higuchi, 2012, A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women, Am J Gastroenterol, 107, 1399, 10.1038/ajg.2012.196
Ananthakrishnan, 2014, Genetic polymorphisms in metabolizing enzymes modifying the association between smoking and inflammatory bowel diseases, Inflamm Bowel Dis, 20, 783, 10.1097/MIB.0000000000000014
Bergeron, 2012, Current smoking differentially affects blood mononuclear cells from patients with Crohn's disease and ulcerative colitis: relevance to its adverse role in the disease, Inflamm Bowel Dis, 18, 1101, 10.1002/ibd.21889
Biedermann, 2014, Smoking cessation alters intestinal microbiota: insights from quantitative investigations on human fecal samples using FISH, Inflamm Bowel Dis, 20, 1496, 10.1097/MIB.0000000000000129
Munyaka, 2014, External influence of early childhood establishment of gut microbiota and subsequent health implications, Front Pediatr, 2, 109, 10.3389/fped.2014.00109
Parkes, 2014, Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect, J Crohns Colitis, 8, 717, 10.1016/j.crohns.2014.02.002
Andersson, 2001, Appendectomy and protection against ulcerative colitis, N Engl J Med, 344, 808, 10.1056/NEJM200103153441104
Koutroubakis, 2000, Appendectomy and the development of ulcerative colitis: results of a metaanalysis of published case-control studies, Am J Gastroenterol, 95, 171, 10.1111/j.1572-0241.2000.01680.x
Kostic, 2014, The microbiome in inflammatory bowel disease: current status and the future ahead, Gastroenterology, 146, 1489, 10.1053/j.gastro.2014.02.009
Piovani, 2019, Environmental risk factors for inflammatory bowel diseases: an umbrella review of meta-analyses, Gastroenterology, 157, 647, 10.1053/j.gastro.2019.04.016
Penders, 2006, Factors influencing the composition of the intestinal microbiota in early infancy, Pediatrics, 118, 511, 10.1542/peds.2005-2824
Shaw, 2010, Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease, Am J Gastroenterol, 105, 2687, 10.1038/ajg.2010.398
Meyer, 2006, Relapse of inflammatory bowel disease associated with use of nonsteroidal anti-inflammatory drugs, Dig Dis Sci, 51, 168, 10.1007/s10620-006-3103-5
Ungaro, 2014, Antibiotics associated with increased risk of new-onset Crohn's disease but not ulcerative colitis: a meta-analysis, Am J Gastroenterol, 109, 1728, 10.1038/ajg.2014.246
Felder, 2000, Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study, Am J Gastroenterol, 95, 1949, 10.1111/j.1572-0241.2000.02262.x
Ananthakrishnan, 2012, Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort study, Ann Intern Med, 156, 350, 10.7326/0003-4819-156-5-201203060-00007
Chan, 2011, Aspirin in the aetiology of Crohn's disease and ulcerative colitis: a European prospective cohort study, Aliment Pharmacol Ther, 34, 649, 10.1111/j.1365-2036.2011.04784.x